5 results
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc.
4 Jun 24
Additional proxy soliciting materials
5:25pm
to position the Company for sustainable success and build value for shareholders, while staying true to our core focus of delivering therapies to treat
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc.
18 Apr 22
Additional proxy soliciting materials
7:36am
capital, and we do not take that for granted. We look forward to continuing to build a sustainable, value-creating bio-pharmaceutical company. We encourage
- Prev
- 1
- Next